Finanzwire Finanzwire
Basculer en Français
9629 Companies
191458 Keywords
122917 Articles
102032 Press releases
Headlines Articles Press releases Northway Biotech Remove
  1. Home
  2. Companies
  3. Northway Biotech
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/04/2025 at 11:05, 11 months 7 days ago

    Mallia and Northway Biotech Partner for Hair Loss Treatment Protein Manufacturing

    Partnership Biologics Manufacturing SCD83 Protein Alopecia Market Hair Follicle Growth
  • PRESS RELEASE

    published on 02/04/2025 at 11:00, 11 months 7 days ago

    Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment

    Mallia Therapeutics partners with Northway Biotech to develop a safe and effective topical sCD83 treatment for alopecia, leveraging biologics manufacturing expertise
    Biologics Manufacturing Alopecia Market Mallia Therapeutics Northway Biotech CD83 Treatment
    Logo of Northway Biotech
  • PRESS RELEASE

    published on 11/16/2023 at 14:20, 2 years 1 month ago

    The Largest Biotech City in Europe Will Soon Be Built, With an Investment Amounting to 7 Billion Euros

    Logo of Northway Biotech
  • PRESS RELEASE

    published on 05/24/2023 at 18:20, 2 years 7 months ago

    Northway Biotech Set to Launch Advanced Microbial and Mammalian GMP Facilities in Massachusetts

    Logo of Northway Biotech
  • PRESS RELEASE

    published on 05/16/2023 at 14:30, 2 years 7 months ago

    tiakis Biotech AG and Northway Biotech: Successful Tech Transfer and Expansion of Manufacturing Capabilities for Tiprelestat

    Logo of Northway Biotech
Accesswire
  • Published on 01/10/2026 at 05:10, 1 day 19 hours ago

    Sekur Private Data Ltd. Announces Non-Brokered Private Placement

  • Published on 01/10/2026 at 00:45, 1 day 23 hours ago

    Digi Power X Announces Entry into Settlement Agreement

  • Published on 01/09/2026 at 23:30, 2 days ago

    Sun Peak Metals Grants Stock Options

  • Published on 01/09/2026 at 23:30, 2 days ago

    Matador Technologies Announces Grant of Restricted Share Units to Management Team

  • Published on 01/09/2026 at 23:10, 2 days 1 hour ago

    Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction

View all ACCESSWIRE
EQS Group
  • Published on 01/11/2026 at 22:20, 1 hour 51 minutes ago

    Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

  • Published on 01/10/2026 at 21:25, 1 day 2 hours ago

    CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh

  • Published on 01/10/2026 at 13:05, 1 day 11 hours ago

    SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation

  • Published on 01/09/2026 at 21:55, 2 days 2 hours ago

    Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)

  • Published on 01/09/2026 at 18:36, 2 days 5 hours ago

    Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS
Les Echos
  • Published on 01/09/2026 at 18:30, 2 days 5 hours ago

    H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm

  • Published on 01/09/2026 at 17:45, 2 days 6 hours ago

    January 2026

  • Published on 01/09/2026 at 17:45, 2 days 6 hours ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 01/09/2026 at 17:42, 2 days 6 hours ago

    Aéroports de Paris SA - Shares and voting rights as of 31 December 2025

  • Published on 01/08/2026 at 21:00, 3 days 3 hours ago

    Biannual report on SEB S.A.’S liquidity agreement

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy